1-Bromododecane → HCID 20210667, compound
Reaction equation
[C:1]1([N:7]2[C:24]([OH:25])=[C:10]3[N:11]=[CH:12][N:13]=[C:14]([S:15][C:16]([C:19]([O:21][CH2:22][CH3:23])=[O:20])([CH3:18])[CH3:17])[C:9]3=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH2:26](Br)[CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH3:37]>>[C:1]1([N:7]2[C:24]([O:25][CH2:37][CH2:36][CH2:35][CH2:34][CH2:33][CH2:32][CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH3:26])=[C:10]3[N:11]=[CH:12][N:13]=[C:14]([S:15][C:16]([C:19]([O:21][CH2:22][CH3:23])=[O:20])([CH3:18])[CH3:17])[C:9]3=[N:8]2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
3
Procedure
1 g of 2-phenyl-3-hydroxy-7-(1-ethoxycarbonyl-1-methyl-ethylthio)-pyrazolo[4,3-d]pyrimidine and 0.84 g of n-dodecyl bromide were reacted and treated in the same manner as in Example 31 to obtain the desired product.
Workup
- additiontreated in the same manner as in Example 31
Sources & evidence
- ORD record
- ord-335a2c6f69d846eab8c365ff96af4f25
- Source dataset
- uspto-grants-1987_03
- Patent number
- US04654348
Reaction notes
Loading…